|

Anti-CD33 CAR T-cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Anti-CD33 CAR T Cells, Anti-CD33 CAR-T Cells, CD33-CAR T Cells

Pipeline

Phase 1: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Recurrent Adult Acute Myeloid Leukemia1
  • Secondary Acute Myeloid Leukemia1
  • Refractory Acute Myeloid Leukemia1
  • Acute Myeloid Leukemia1
  • Cancer1

Duarte, California1 trial

CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.